observed that the expression level of CCT6A was markedly increased in glioblastoma patients, and its expression was associated with EGFR, speculating that CCT6A might be a potential biomarker of glioblastoma with prognostic significance (41). This evidence concerns the gene CCT6A and glioblastoma.